AVITA Medical, Inc. (RCEL) Q3 2026 Earnings Call Transcript

Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the AVITA Medical, Inc. Third Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. At this time, I would like to turn the call over to Mr. Ben Atkins, Vice President of Investor Relations. Sir, please begin.

Ben Atkins
Vice President of Investor Relations & Corporate Communications

Thank you, operator. Welcome to AVITA Medical’s Third Quarter 2026 Earnings Call. Joining me on today’s call are Cary Vance, President and Chief Executive Officer; and David O’Toole, Chief Financial Officer. Today’s earnings release and presentation are available on our website at www.avitamedical.com under the Investor Relations section. Before we begin, I would like to remind you that this call includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results to differ materially from any expectations expressed or implied by the forward-looking statements. Please review our most recent filings with the SEC for comprehensive descriptions of the risk factors. Any forward-looking statements provided during this call are based on management’s expectations as of today. I will now turn the call over to Cary.

Cary Vance
President, CEO & Executive Director

Good afternoon in the U.S., and good morning in Australia. As always, we appreciate you making the time to